Recall: D-502-2013
Class II - Potentially Harmful
Class IIClassification
2013-04-30Initiated
TerminatedStatus
Hospira Inc.Firm
Product
DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag, Rx only, HOPIRA, INC., LAKE FOREST, IL 60045 NDC 0409-2346-32
Reason
Lack of Assurance of Sterility: Confirmed report of leaking in the primary container.
Distribution
Nationwide and Puerto Rico
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.